Zenlabs Ethica Ltd
Zenlabs Ethica (BSE)

36.25

23.60
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Zenlabs Ethica Ltd stands at 4 against 3, three months back.

Zenlabs Ethica Limited, formerly Neelkanth Technologies Limited, is an India-based pharmaceutical company. The Company is engaged in trading/marketing in pharmaceutical products. The Company is involved in marketing and exporting a range of drugs, including analgesics and anti-inflammatory; neurological disorders; ear, eye and nasal drops; anti-diabetic; anti-depressant; antiviral; anti-emetic; steroids and anabolic steroids; anti-hypertensive drugs; anti allergic, anti cold and cough syrup; nutraceuticals, and ayurvedic preparation. It offers a range of products, which include ACLOZEN, ACLOZEN-MR, ETORIZEN-90/120, KETROZ, CLOBYTE-S LOTION, FLUZEN GEL, BARTONE, COBAZEN, ZENOBAL, DEXZEN-C, ZENDRE, DAOZEN-5, VOGLIZEN, ALPRA-P, ZENSERT-50, AVOZEN, PROCETA, PHENERZEN, FERZEN FORTE, ZECOFOL, ZENCAL PLUS, CINARAZEN-25, POLARZEN, BEXZYME PLUS, ZENCID and SPASZEN. It also offers other pharmaceutical drugs, which include ALCONIL, HEXIZEN, ZENSTONE, ZENOLIV, ZENTRALKA, BISCOZEN and CLOPE.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
39.77
100 DMA ()
35.28
200 DMA ()
31.72
52 Weeks Range
19.25
54.80
Street View :-
Bearish
Open ZERO Brokerage Demat Account